Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1984 2
1989 1
1990 2
1991 1
1993 1
1994 1
1995 4
1996 4
1997 1
1998 5
1999 3
2000 2
2001 4
2002 4
2003 6
2004 6
2005 2
2006 4
2007 6
2008 6
2009 4
2010 5
2011 1
2012 2
2013 5
2015 3
2016 3
2017 5
2018 6
2019 4
2020 4
2021 1
2024 0

Text availability

Article attribute

Article type

Publication date

Similar articles for PMID: 11110349

103 results

Results by year

Filters applied: . Clear all
Page 1
Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT).
ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial. JAMA. 2002 Dec 18;288(23):2998-3007. doi: 10.1001/jama.288.23.2998. JAMA. 2002. PMID: 12479764 Clinical Trial.
Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT).
Margolis KL, Dunn K, Simpson LM, Ford CE, Williamson JD, Gordon DJ, Einhorn PT, Probstfield JL; ALLHAT Collaborative Research Group. Margolis KL, et al. Am Heart J. 2009 Dec;158(6):948-55. doi: 10.1016/j.ahj.2009.10.001. Am Heart J. 2009. PMID: 19958861 Free PMC article. Clinical Trial.
Characteristics and Cardiovascular Disease Event Rates among African Americans and Whites Who Meet the Further Cardiovascular Outcomes Research with PCSK9 Inhibition in Subjects with Elevated Risk (FOURIER) Trial Inclusion Criteria.
Colantonio LD, Monda KL, Rosenson RS, Brown TM, Mues KE, Howard G, Safford MM, Yedigarova L, Farkouh ME, Muntner P. Colantonio LD, et al. Cardiovasc Drugs Ther. 2019 Apr;33(2):189-199. doi: 10.1007/s10557-019-06864-2. Cardiovasc Drugs Ther. 2019. PMID: 30746585 Free PMC article.
103 results